Liang Huang

Liang Huang

Auto-generated profile, based on publicly available information

Liang Huang

Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Journal of Surgical Research
Verified
Journal Article
Closed access
RZRu-Hai Zou
Ru-Hai Zou
ALAn-Hua Li
An-Hua Li
FHFeng Han
Feng Han
JHJian Hong
Jian Hong
BLBinkui Li
Binkui Li
YYYunfei Yuan
Yunfei Yuan

1 October 2018 in Gastroenterology Report
Verified
Journal Article
Open access
PDF file
HLHong-Cheng Lin
Hong-Cheng Lin
HCHua-Xian Chen
Hua-Xian Chen
LHLiang Huang
Liang Huang
YZYaxi Zhu
Yaxi Zhu
QZQian ZHOU
Qian ZHOU
JWJian-Ping Wang
Jian-Ping Wang
The present study was designed to evaluate the functional outcome of stapled transanal rectal resection (STARR) and to examine the relationship between the population density of the interstitial cells of Cajal (ICC) and the efficacy of the STARR operation in the management of obstructed defecation syndrome (ODS) patients. Full-thickness rectal samples were obtained from 50 ODS patients who underwent STARR. Samples were analysed using ICC immunohistochemistry. Clinical and functional parameters obtained with defecography and anorectal manometry were compared with 20 controls. ICCs were significantly decreased in patients in the submucosal (SM), intramuscular (IM) and myenteric (MY) regions when compared with the control group (P < 0.05). The mean pre-operative Cleveland Constipation Score (CCS) was 24.2 ± 4.1, whilst the CCS at 1, 2, 3, 4 and 5 years post-operatively decreased significantly (P < 0.05). At 3 post-operative years, 58.3% (28/48) of the patients reported a favorable outcome (CCS ≤ 10). On univariate analysis, the functional results were worse in those with pre-operative digitation (P = 0.017), a decreased ICC-MY cell population (P = 0.067), a higher resting anal canal pressure (P = 0.039) and a higher rectal sensory threshold (P = 0.073). Multivariate analysis showed the decreased ICC-MY cell population was an independent predictor for low unfavorable functional outcome (odds ratio = 0.097, 95% confidence interval: 0.012–0.766). STARR achieved acceptable results at the cost of a slight deterioration over a more prolonged follow-up. Patients with a decreased ICC number in the rectal specimen showed an unfavorable functional outcome where pre-operative histological assessment of a full-thickness rectal sample might predict for the functional outcome following STARR.

21 August 2024 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
XJXiaoliang Jin
Xiaoliang Jin
QZQiujun Zhou
Qiujun Zhou
BLBin Lyu
Bin Lyu
CZChunli Zhang
Chunli Zhang
LHLiang Huang
Liang Huang
Background Most endoscopists believe that higher resolution improves lesion detection rates. However, existing studies primarily compared the detection rates of white light endoscopy (WLE) and other imaging modalities. Our previous study demonstrated the advantages of magnifying endoscopy from general endoscopy for lesion detection, prompting further investigation into the variations in lesion detection rates across endoscopes with different resolutions. Methods Endoscopic and corresponding pathological data from our medical unit over the past 5 years were analyzed. We excluded specific-purpose endoscopic procedures to ensure the natural randomization of the data. Baseline adjustment and risk factor analyses used multi-group propensity score matching and logistic regression. Results The overall lesion detection rate was significantly higher with high-quality endoscopy (Q-endoscopy) compared to high-definition endoscopy (H-endoscopy) and high definition and quality endoscopy (HQ-endoscopy) (34.4% vs. 30.2% vs. 29.6%, P = 0.001). Similar results were observed for elevated lesions (25.7% vs. 21.0% vs. 22.9%, P = 0.001) and depressed lesions (6.6% vs. 6.2% vs. 3.6%, P < 0.001). HQ-endoscopy had a superior detection rate for superficial lesions compared to both H- and Q-endoscopies (3.0% vs. 2.8% vs. 1.8%, P = 0.041). However, there were no significant differences in neoplastic detection rate or missed neoplastic lesion rate among the three groups. Conclusion Q-endoscopy is superior in detecting non-superficial lesions, while HQ-endoscopy is better at detecting superficial lesions. However, there were no statistically significant differences in detecting or omitting neoplastic lesions among the three endoscopic examinations.

1 February 2013 in International Journal of Pharmacology
Verified
Journal Article
Open access
BRBin Ren
Bin Ren
BWBinghua Wei
Binghua Wei
RLRuiming Li
Ruiming Li
LHLiang Huang
Liang Huang
XHXiaodan Hong
Xiaodan Hong
XCXiao Chen
Xiao Chen

14 January 2025 in Endoscopy
Verified
Journal Article
Open access
PDF file
YHYue Hu
Yue Hu
BLBin Lu
Bin Lu
YXYi Xu
Yi Xu
LHLiang Huang
Liang Huang
A 55-year-old woman had a history of acute pancreatitis 4 years prior, with the development of a large pancreatic pseudocyst (62 mm × 77 mm × 72mm) in the pancreatic tail ([Fig. 1]). Endoscopic ultrasound (EUS)-guided pseudocyst drainage was successfully performed with a 10 Fr plastic double-pigtail stent. Post-procedural follow-up computed tomography (CT) imaging at 1 month revealed persistent pseudocyst dimensions with stent migration into the cystic cavity ([Fig. 2]). After obtaining informed consent, the patient was referred for re-endoscopic pseudocyst drainage. However, we did not observe any small orifice at the location of the previously applied stent during the endoscopy. EUS images confirmed stent migration into the pseudocyst lumen. We proceeded with transgastric puncture of the pseudocyst using a 19-gauge fine-needle aspiration needle under EUS guidance. A 0.035-inch guidewire was advanced through the needle, and the tract was dilated to 10 mm ([Fig. 3] a). After entering the pseudocyst lumen, the intracystic migrated stents were then removed by using foreign body forceps ([Fig. 3] b). Surprisingly, we found a full-layer perforation of the fistulous tract following balloon dilation ([Fig. 3] c). To simultaneously address perforation and cyst drainage, we placed a fully covered metal stent through the cystogastrostomy, fixing the proximal end on the stomach side with metal clips ([Fig. 4] and [Video 1]). Effective drainage of the pseudocyst was observed, and the patient remained well and was discharged after 6 days. At follow-up 3 months later, an abdominal CT scan showed complete resolution of the pseudocyst, the stent was removed endoscopically ([Fig. 5]). Stent migration represents a common complication in the endoscopic management of pancreatic pseudocysts [1], with endoscopic salvage procedures offering viable therapeutic options [2] [3]. This case highlights the potential risk of perforation during endoscopic re-establishment of the gastro-pancreatic tunnel. The deployment of covered stents demonstrates efficacy in drainage and perforation closure, sparing patients from the morbidity associated with surgical intervention [4]. Endoscopy_UCTN_Code_TTT_1AO_2AO Article published online: 14 May 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

1 July 2021
Verified
Conference Paper
Closed access
JLjian Li
jian Li
JZJun Zhang
Jun Zhang
XWXingye Wu
Xingye Wu
CWChao Wu
Chao Wu
JDJuan Dong
Juan Dong
LSLin Shen
Lin Shen
Objective: To evaluate the pharmacokinetic (PK) parameters of ripretinib and its active metabolite in Chinese patients with gastrointestinal stromal tumor (GIST), and to examine potential ethnic differences in drug exposure between Chinese and the global patient populations using both population and non-compartmental PK methods. Methods: An ongoing clinical phase 2 bridging study in China had enrolled 29 advanced GIST patients who underwent intensive or sparse PK sampling at a ripretinib dose of 150 mg QD. The plasma samples were collected and then analyzed with LC-MS/MS to quantitatively determine the concentration of ripretinib and its active metabolite. Non-compartmental analysis (NCA) was performed using Phoenix WinNonlin® software and population PK analysis was conducted with nonlinear mixed-effect modeling (NONMEM) and R software. In total, there were 15 Chinese GIST patients included in the NCA analysis and 379 patients (350 from global studies and 29 from China bridging study) were involved in the population PK analysis. Evaluation of potential exposure differences between the Chinese population and the global population were based on steady state NCA data and population PK modeling results. Results: Based on the NCA results, the PK exposure of ripretinib and its active metabolite in the Chinese population were similar to that in the global population: 1) The steady state AUC of parent drug (geometric mean of AUC0-12 was 7280 hr*ng/mL, CV 53.8%) in Chinese patients showed differences of 28.2% compared with the global population. 2) The steady state AUC of active metabolite (geometric mean of AUC0-12 was 8490 hr*ng/mL, CV 80.7%) in Chinese patients showed differences of 19.1% compared with the global population. 3) For Cmax of parent drug in Chinese patients, the multiple dosing (geometric mean of Cmax was 787 ng/mL, CV 50.2%) showed differences of 3.4% compared with the global population. 4) For Cmax of active metabolite in Chinese patients, the multiple dosing (geometric mean of Cmax was 860 ng/mL, CV 72.2%) showed differences of 7.0% compared with the global population. In addition, the population PK results showed no ethnical effect on steady-state exposure of parent and its active metabolite between Asians and non-Asians (p > 0.05) and between Chinese and non-Chinese patients (p > 0.05). Conclusion: Based on population PK modeling data and the NCA results of ripretinib and its active metabolite, no significant PK differences were observed between the Chinese patient population and the global patient population. Citation Format: Jian Li, Jun Zhang, Xingye Wu, Chao Wu, Juan Dong, Liang Huang, Lin Shen. Population and non-compartmental pharmacokinetic analysis of ripretinib and its active metabolite in Chinese patients with gastrointestinal stromal tumor [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr LB126.